Surface markers for the identification of cancer stem cells

Methods in Molecular Biology

Volumn 1692, Issue , 2018, Pages 17-29

  Gopalan, Vinod ^a   Islam, Farhadul ^a   Lam, Alfred King yin ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Cancer; Detection; Isolation; Markers; Methods; Stem cell

Indexed keywords

CELL SURFACE MARKER; HERMES ANTIGEN; MOLECULAR MARKER; TUMOR MARKER;

ANALYTIC METHOD; ANIMAL CELL; ANTIGEN SPECIFICITY; CANCER STEM CELL; CELL ISOLATION; CELL SELECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; XENOTRANSPLANTATION; HUMAN; METABOLISM; NEOPLASM; XENOGRAFT;

BIOMARKERS, TUMOR; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 85030777659     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-7401-6_2     Document Type: Chapter

References (53)

1. Islam F, Gopalan V, Smith RA, Lam AK (2015) Translational potential of cancer stem cells: a review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment. Exp Cell Res 335:135–147
2. Frank NY, Schatton T, Frank MH (2010) The therapeutic promise of the cancer stem cell concept. J Clin Invest 120:41–50
3. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB (2009) Tumourinitiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8:806–823
4. Islam F, Qiao B, Smith RA, Gopalan V, Lam AK (2015) Cancer stem cell: fundamental experimental pathological concepts and updates. Exp Mol Pathol 98:184–191
5. Major AG, Pitty LP, Farah CS (2013) Cancer stem cell markers in head and neck squamous cell carcinoma. Stem Cells Int 2013:319489
6. Sayed SI, Dwivedi RC, Katna R, Garg A, Pathak KA, Nutting CM, Rhys-Evans P, Harrington KJ, Kazi R (2011) Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral Oncol 47:237–243
7. Deonarain MP, Kousparou CA, Epenetos AA (2009) Antibodies targeting cancer stem cells: a new paradigm in immunotherapy? MAbs 1:12–25
8. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737
9. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identification of tumourigenic prostate cancer stem cells. Cancer Res 65:10946–10951
10. O’Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106–110
11. Dirks PB (2008) Brain tumour stem cells: bringing order to the chaos of brain cancer. J Clin Oncol 26:2916–2924
12. Zhao W, Ji X, Zhang F, Li L, Ma L (2012) Embryonic stem cell markers. Molecules 17:6196–6236
13. Shah A, Patel S, Pathak J, Swain N, Kumar S (2014) The evolving concepts of cancer stem cells in head and neck squamous cell carcinoma. Sci World J 2014:842491
14. Karsten U, Goletz S (2013) What makes cancer stem cell markers different? Springerplus 2:301
15. Hsu CC, Chiang CW, Cheng HC, Chang WT, Chou CY, Tsai HW, Lee CT, Wu ZH, Lee TY, Chao A, Chow NH, Ho CL (2011) Identifying LRRC16B as an oncofetal gene with transforming enhancing capability using a combined bioinformatics and experimental approach. Oncogene 30:654–667
16. Hennen E, Faissner A (2012) Lewis X: A neural stem cell specific glycan? Int J Biochem Cell Biol 44:830–833
17. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, Cavazzin C, Gritti A, Piccini A, Porro D, Santinami M, Invernici G, Parati E, Alessandri G, LaPorta CA (2007) Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 43:935–946
18. Guo W, Lasky JL, Chang C-J, Mosessian S, Lewis X, Xiao Y, Yeh JE, Chen JY, Iruela- Arispe ML, Varella-Garcia M, Wu H (2008) Multi-genetic events collaboratively contribute to Pten-null leukemia stem-cell formation. Nature 453:529–533
19. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13–24
20. Cheung AM, Wan TS, Leung JC, Chan LY, Huang H, Kwong YL, Liang R, Leung AY (2007) Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/ SCID engrafting potential. Leukemia 21:1423–1430
21. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555–567
22. Carpentino JE, Hynes MJ, Appelman HD, Zheng T, Steindler DA, Scott EW, Huang EH (2009) Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. Cancer Res 69:8208–8215
23. Li R, Wu X, Wei H, Tian S (2013) Characterization of side population cells isolated from the gastric cancer cell line SGC7901. Oncol Lett 5:877–883
24. Lianidou ES, Markou A (2011) Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem 57:1242–1255
25. Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, La Noce M, Laino L, De Francesco F, Papaccio G (2013) Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J 27:13–24
26. Milne AN, Carneiro F, O’Morain C, Offerhaus GJ (2009) Nature meets nurture: molecular genetics of gastric cancer. Hum Genet 126:615–628
27. Podberezin M, Wen J, Chang CC (2013) Cancer stem cells: a review of potential clinical applications. Arch Pathol Lab Med 137:1111–1116
28. Greve B, Beller C, Cassens U, Sibrowski W, Göhde W (2006) The impact of erythrocyte lysing procedures on the recovery of hematopoietic progenitor cells in flow cytometric analysis. Stem Cells 24:793–799
29. Fulawka L, Donizy P, Halon A (2014) Cancer stem cells - the current status of an old concept: literature review and clinical approaches. Biol Res 47:66
30. Wang K, Wei G, Liu D (2012) CD19: a biomarker for B cell development, lymphoma diagnosis and therapy. Exp Hematol Oncol 1:36
31. Ferrero E, Malavasi F (1999) The metamorphosis of a molecule: from soluble enzyme to the leukocyte receptor CD38. J Leukoc Biol 65:151–161
32. Andrews RG, Singer JW, Bernstein ID (1989) Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 169:1721–1731
33. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signaling regulators. Nat Rev Mol Cell Biol 4:33–45
34. Snyder EL, Bailey D, Shipitsin M, Polyak K, Loda M(2009) Identification of CD44v6(þ)/ CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies. Lab Investig 89:857–866
35. Vassilopoulos A, Chisholm C, Lahusen T, Zheng H, Deng CX (2014) A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1- associated mouse model of breast cancer. Oncogene 33:5477–5482
36. Lv X, Wang Y, Song Y, Pang X, Li H (2016) Association between ALDH1þ/CD133þ stem-like cells and tumor angiogenesis in invasive ductal breast carcinoma. Oncol Lett 11:1750–1756
37. Farhana L, Antaki F, Anees MR, Nangia- Makker P, Judd S, Hadden T, Levi E, Murshed F, Yu Y, Van Buren E, Ahmed K, Dyson G, Majumdar AP (2016) Role of cancer stem cells in racial disparity in colorectal cancer. Cancer Med 5:1268–1278
38. Grunt TW, Hebar A, Laffer S, Wagner R, Peter B, Herrmann H, Graf A, Bilban M, Posch M, Hoermann G, Mayerhofer M, Eisenwort G, Zielinski CC, Selzer E, Valent P (2015) Prominin-1 (CD133, AC133) and dipeptidylpeptidase IV (CD26) are indicators of infinitive growth in colon cancer cells. Am J Cancer Res 5:560–574
39. Mărgaritescu C, Pirici D, Cherciu I, Bărbălan A, Cârtână T, Săftoiu A (2014) CD133/ CD166/Ki-67 triple immunofluorescence assessment for putative cancer stem cells in colon carcinoma. J Gastrointestin Liver Dis 23:161–170
40. Vaiopoulos AG, Kostakis ID, Koutsilieris M, Papavassiliou AG (2012) Colorectal cancer stem cells. Stem Cells 30:363–371
41. He J, Liu Y, Zhu T, Zhu J, Dimeco F, Vescovi AL, Heth JA, Muraszko KM, Fan X, Lubman DM (2012) CD90 is identified as a candidate marker for cancer stem cells in primary highgrade gliomas using tissue microarrays. Mol Cell Proteomics 11:M111.010744
42. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB (2004) Identification of human brain tumour initiating cells. Nature 432:396–401
43. Dahlrot RH, Hermansen SK, Hansen S, Kristensen BW (2013) What is the clinical value of cancer stem cell markers in gliomas? Int J Clin Exp Pathol 6:334–348
44. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104:973–978
45. Murillo-Sauca O, Chung MK, Shin JH, Karamboulas C, Kwok S, Jung YH, Oakley R, Tysome JR, Farnebo LO, Kaplan MJ, Sirjani D, Divi V, Holsinger FC, Tomeh C, Nichols A, Le QT, Colevas AD, Kong CS, Uppaluri R, Lewis JS Jr, Ailles LE, Sunwoo JB (2014) CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma. Oncotarget 5:6854–6866
46. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65:9328–9337
47. Sun JH, Luo Q, Liu LL, Song GB (2016) Liver cancer stem cell markers: progression and therapeutic implications. World J Gastroenterol 22:3547–3557
48. Miyata T, Yoshimatsu T, So T, Oyama T, Uramoto H, Osaki T, Nakanishi R, Tanaka F, Nagaya H, Gotoh A (2015) Cancer stem cell markers in lung cancer. Personalized Medicine Universe 4:40–45
49. Zhu YY, Yuan Z (2015) Pancreatic cancer stem cells. Am J Cancer Res 5:894–906
50. Moltzahn F, Thalmann GN (2013) Cancer stem cells in prostate cancer. Transl Androl Urol 2:242–253
51. Qian X, Tan C, Wang F, Yang B, Ge Y, Guan Z, Cai J (2016) Esophageal cancer stem cells and implications for future therapeutics. Onco Targets Ther 9:2247–2254
52. Yao T, Lu R, Zhang Y, Zhang Y, Zhao C, Lin R, Lin Z (2015) Cervical cancer stem cells. Cell Prolif 48:611–625
53. Brungs D, Aghmesheh M, Vine KL, Becker TM, Carolan MG, Ranson M (2016) Gastric cancer stem cells: evidence, potential markers, and clinical implications. J Gastroenterol 51:313–326